Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insilico Medicine
Biotech
Lilly continues AI push, inking $100M-plus deal with Insilico
Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using AI to discover new drugs.
Gabrielle Masson
Nov 10, 2025 9:00am
Insilico Medicine nets $110M for new trials, robotic helpers
Mar 12, 2025 11:00am
Insilico posts benchmarks from 22 AI-designed drug candidates
Feb 11, 2025 9:00am
Insilico Medicine, Menarini sign second $500M+ cancer drug deal
Jan 10, 2025 9:30am
After phase 2 data, Insilico plots pivotal lung disease trial
Nov 12, 2024 1:34pm
Big pharma, biotech ‘won't necessarily be symbiotic’ in AI: S&P
Oct 2, 2024 11:23am
